###### Strengths and limitations of this study

-   Systematic review and meta-analysis of prospective cohort studies.

-   First rigorous evidence synthesis investigating the natural clinical course of disability and pain in patients following primary lumbar discectomy.

-   Potential inclusion of large populations with multiple outcome assessment points and the use of a good consistency of measures to assess pain and disability.

-   Limitations may include issues of poor reporting affecting risk of bias assessment and confidence in results.

Background {#s1}
==========

Rationale {#s1a}
---------

Eighty per cent of the population is affected by low back pain at some point within their lifetime[@R1], contributing to estimates of £10.7 billion annually for lost productivity and sickness/disability benefit.[@R2] The largest single component of expenditure (31%) for management of low back pain is surgery.[@R2] A common surgical procedure is lumbar discectomy to excise prolapsed intervertebral disc material when causing severe leg pain. In the UK National Health Service, primary lumbar discectomy operations have increased from 7043 (2001/2002 financial year) to 8478 in the 2013/2014 financial year.[@R3] Paralleling this increase, the mean hospital stay has reduced from 6.6 days (1999--2000) to 2.3 days (2013/2014).[@R3] International data provide annual estimates of 12 000 operations in the Netherlands[@R4] and 287 122 in the USA.[@R5]

Although lumbar discectomy success rates are reported as high (46--75% at 6--8 weeks, and 78--95% at 1--2 years postsurgery),[@R6] ongoing problems are an issue for a substantial number of patients. The evidence suggests 30--70% of patients continue to experience pain,[@R7] and that 3--12% required further surgery.[@R8] Approximately, 14% of patients required revision surgery in the UK in 2013/2014 (1164 operations).[@R3] Ongoing problems are a key issue for this patient population from a quality of life perspective, particularly owing to the mean age for surgery of 45 years being of working age.

Rehabilitation for this population is also problematic, with documented variability of surgeon and physiotherapist advice and management post operatively.[@R9] [@R10] Whether patients receive rehabilitation is dependent on where they live and local practices. If they do receive rehabilitation, the content and number of sessions varies considerably.[@R10]

Our recent systematic review (16 trials) evaluating effectiveness of all physiotherapy interventions postprimary single level lumbar discectomy[@R11] and an updated Cochrane systematic review (22 trials) of rehabilitation programmes (including physiotherapy) postlumbar disc surgery[@R6] identified variability of timing of interventions and outcomes as a key issue. Statistical pooling was limited, but meta-analyses suggested a short-term positive effect of physiotherapy on pain, function and disability starting 4--6 weeks postsurgery, and a potential benefit from more intensive exercise interventions. However, the influence of the natural course of pain and disability following the operation on outcomes is unclear, and this identifies a wider issue that a clear understanding of the natural course is required to inform effective management. In addition, very different definitions of recovery are used in the literature making it difficult to obtain pooled estimates of recovery rates. Postoperative rehabilitation could possibly be harmful for patients if outcomes of the natural clinical course are better than outcomes of rehabilitation interventions. Additionally, a clear trend in recovery could indicate optimal timing for rehabilitation.

To enhance our understanding and inform future research, detail of the natural clinical course of pain and disability following lumbar discectomy is required. This knowledge is important as future research needs to evaluate how intervention outcomes relate to the natural course. To date, there has been no systematic review collating these data in this population.

Objective {#s1b}
---------

To investigate the natural clinical course of pain and disability[@R12] in patients aged \>16 years post first-time lumbar discectomy. If possible, subgroup analyses will be conducted for type of surgery, duration of symptoms prior to surgery and age at time of surgery.[@R13]

Methods/design {#s2}
==============

Methodology {#s2a}
-----------

This protocol following method guidelines by the Cochrane Back and Neck Group,[@R14] Cochrane Handbook[@R15] and PRISMA-P[@R16] will inform the conduct of a systematic review. The protocol is registered with PROSPERO: CRD42015020806.[@R17]

Amendments {#s2b}
----------

It was initially planned to investigate the natural history of a wider range of outcomes. However, the scoping search identified a greater number of prospective studies than anticipated. The protocol was revised, on 26 May 2015, to reflect a focus on disability and pain outcomes, and revised on 20 January 2016 to further develop search terms/databases, amend search dates and plans for data synthesis; and another author was recruited to provide statistical guidance.

Eligibility criteria {#s2c}
--------------------

### Participants {#s2c1}

Adult patients who have undergone first-time lumbar discectomy/microdiscectomy/automated percutaneous discectomy, with no complications (eg, general (anaesthetic, cardiopulmonary and thromboembolic) and surgical including cauda equina),[@R18] and aged \>16 years. Studies including participants undergoing revision surgery will be excluded if data cannot be obtained for the first-time surgery participants only. All clinical settings and providers were included. Any reported treatments postsurgery will be recorded carefully and evaluated as part of the risk of bias assessment.

### Outcome measures {#s2c2}

Measurements reported on one or more outcomes of pain and disability,[@R12] with a baseline presurgery measurement.

### Studies {#s2c3}

Inception prospective cohort studies that included a well-defined inception cohort (episode inception, ie, point of surgery) of participants. The prospective cohort is the preferred design to enable control of unwarranted influences, and enables a stronger case for cause and effect relationships to be postulated.

Information sources {#s2d}
-------------------

The search will employ sensitive topic-based strategies designed for each database from inception to 31 January 2016. There will be no language or geographical restrictions.

Databases: CINAHL (via EBSCOhost 1981--);EMBASE (via EBSCOhost 1974--);PubMed;MEDLINE (via OVIDSP 1946--);ZETOC (1993--);Scopus (1996--);TRIP (non-Premium version);Science Citation Index and Social Science Citation Index (*journal search terms: Spine, neurology, orthopaedics*);An additional search of the Cochrane Back and Neck Group website (<http://back.cochrane.org/our-reviews>), Cochrane Database of Systematic Reviews, and MEDLINE will identify any relevant systematic reviews to enable checking of their reference lists.

Unpublished research: British National Bibliography for Report Literature (search terms: spine, disc, discectomy, surgery, sciatica);Ethos (search terms: spine, disc, discectomy, surgery, sciatica);OpenGrey (see Boolean search, [box 1](#bx1){ref-type="boxed-text"}). Box 1OpenGrey/EBSCOhost search strategy('leg pain' OR 'back pain' OR backache OR 'low-back pain' OR sciatica OR 'sciatic neuropathy' OR lumbago OR 'back disorders' OR dorsalgia) AND ('disc degeneration' OR 'disc prolapse' OR 'disc herniation' OR 'intervertebral disc\$' OR radiculopathies OR nerve root compression) AND (discectom\* OR diskectom\* OR microdisc\* OR micro-disc OR microdisk\* OR micro-disk\* OR nucleotomy OR nucleotomies) AND (inception OR survival OR 'life tables' OR 'log rank' OR prospective OR cohort OR 'follow-up' OR 'follow up study')

Search strategy {#s2e}
---------------

The search strategy will include (1) the study population terms suggested by the Cochrane Back and Neck Group, and (2) a strategy for searching MEDLINE for prognosis studies. Study population terms: Population: Leg pain and/or low back pain

('leg pain' OR 'back pain' OR exp backache OR 'low-back pain' OR sciatica OR 'sciatic neuropathy' OR lumbago OR 'back disorders' OR dorsalgia).

AND Target condition: Prolapsed intervertebral disc

('disc adj degeneration' OR 'disc adj prolapse' OR 'disc adj herniation' OR 'intervertebral disc\$' OR radiculopathies\[mesh\] OR 'nerve root compression'\[mesh\]).

AND Intervention: lumbar discectomy

(discectom\* OR diskectom\* OR microdisc\* OR micro-disc OR microdisk\* OR micro-disk\* OR nucleotomy\[mesh\] OR nucleotomies\[mesh\]).

AND Methodology: prospective cohort studies

(inception OR survival OR 'life tables' OR 'log rank' OR prospective OR cohort OR 'follow-up' OR 'follow-up study').

Examples of searches that will be used include: MEDLINE OvidSP advanced search ([box 2](#bx2){ref-type="boxed-text"}), OpenGrey and EBSCOhost Boolean search ([box 1](#bx1){ref-type="boxed-text"}) and SCOPUS search ([table 1](#BMJOPEN2015010571TB1){ref-type="table"}). Syntax (truncation, wildcards and quotation marks) and operators will be amended according to the specific databases. Box 2Example of an advanced search strategy---MEDLINE OvidSP 1946 to 13 January 2016Stages and detail of search strategy1. 'leg pain.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]2. 'back pain.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]3. backache.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]4. 'low-back pain.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]5. sciatica.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]6. 'sciatic neuropathy.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]7. lumbago.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]8. 'back disorder\$.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]9. dorsalgia.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 911. (disc adj degeneration).m_titl.12. exp spine/13. (disc adj degeneration).mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]14. (disc adj prolapse).mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]15. (disc adj herniation).mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]16. 'intervertebral disc\$.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]17. radiculopathy.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]18. radiculopathies.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]19. 11 or 12 or 13 or 14 or 15 or 16 or 17 or 1820. diskectom\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]21. discectom\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]22. microdisk\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]23. micro-disk\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]24. microdisc\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]25. micro-disc\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]26. (disc adj4 surgery).mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]27. nucleotomy.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]28. nucleotomies.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]29. 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 2830. inception.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]31. survival.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]32. 'life tables.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]33. 'log rank.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]34. prospective.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]35. cohort.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]36. 'follow-up study.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]37. 30 or 31 or 32 or 33 or 34 or 35 or 3638. 10 and 19 and 29 and 37 Box 2ContinuedStages and detail of search strategy1. 'leg pain.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]2. 'back pain.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]3. backache.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]4. 'low-back pain.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]5. sciatica.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]6. 'sciatic neuropathy.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]7. lumbago.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]8. 'back disorder\$.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]9. dorsalgia.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 911. (disc adj degeneration).m_titl.12. exp spine/13. (disc adj degeneration).mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]14. (disc adj prolapse).mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]15. (disc adj herniation).mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]16. 'intervertebral disc\$.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]17. radiculopathy.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]18. radiculopathies.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]19. 11 or 12 or 13 or 14 or 15 or 16 or 17 or 1820. diskectom\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]21. discectom\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]22. microdisk\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]23. micro-disk\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]24. microdisc\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]25. micro-disc\$.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]26. (disc adj4 surgery).mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]27. nucleotomy.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]28. nucleotomies.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]29. 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 2830. inception.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]31. survival.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]32. 'life tables.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]33. 'log rank.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]34. prospective.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]35. cohort.mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]36. 'follow-up study.'mp. \[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]37. 30 or 31 or 32 or 33 or 34 or 35 or 3638. 10 and 19 and 29 and 37

###### 

Data extraction variables

  ----------------------------------------------------------------------------------------------------------------------------
  Content                               Data items
  ------------------------------------- --------------------------------------------------------------------------------------
  Prospective study information         Author(s)\
                                        Year of publication

  Surgical procedure                    Description of surgical procedure, for example, discectomy, microdiscectomy

  Mean duration of symptoms             Mean and SD in months for duration of symptoms prior to surgery

  Number of participants                N=?

  Setting                               Nature of clinical setting\
                                        Country

  Intervention during follow-up phase   Reported surgical, pharmacological or conservative management during follow-up phase

  Pain outcome measure                  Detail of pain outcome measure

  Disability outcome measure            Detail of disability outcome measure

  Baseline                              Detail of preoperative timing of baseline assessment

  Follow-up assessment points           Detail of timing of postoperative timing of follow-up assessments

  Losses to follow-up                   Detail of losses to follow-up at postoperative assessment points

  Results                               Mean and SD of outcomes at baseline and follow-up assessment points
  ----------------------------------------------------------------------------------------------------------------------------

Reference list searches of all relevant publications will take place online where accessible. The reference lists of articles not available online will be searched manually. No filters will be applied, so where feasible, duplicates will be removed. Authors of grey literature will be contacted when conference abstracts and proceedings are found.

Study records {#s2f}
-------------

### Data management {#s2f1}

Records will be managed through EndNote; specific software for managing bibliographies.

### Selection process {#s2f2}

Two reviewers (AR/PG) will search information sources independently and assess identified studies for inclusion, facilitated by grading each eligibility criterion as eligible/not eligible/might be eligible.[@R19] The full text of a study will be reviewed and the study considered potentially relevant when it cannot be clearly excluded on the basis of its title and abstract alone[@R20] following discussions between the two independent reviewers. Full text will be obtained for abstracts with insufficient information or in a situation of disagreement. A study will be included when both reviewers independently assess it as satisfying the inclusion criteria from the full text. A third reviewer (NH) will mediate in the event of disagreement following discussion.[@R14] The process of decision-making for inclusion based on the eligibility criteria will be initially piloted on five articles to ensure that the criteria and interpretation of studies work effectively. The PRISMA flow diagram[@R21] will document included and excluded studies, along with the reasons for exclusion.

### Data collection process {#s2f3}

Using a standardised form, two reviewers (AR/PG) will extract the data independently. A third reviewer (NH) will check the data for consistency and clarity. Any discrepancies in the data will be discussed and amended. The standardised form was iteratively developed and will be pilot tested on ≥5 papers by the two reviewers.

Data items {#s2g}
----------

Data extracted for each cohort will include the summary data detailed in [table 1](#BMJOPEN2015010571TB1){ref-type="table"}.

Outcomes and prioritisation {#s2h}
---------------------------

Outcomes of interest were predefined as tools to measure pain and disability, as reflected in the domains from the WHO\'s International Classification of Functioning, Disability and Health.[@R12] Outcomes with established measurement properties (reliability, validity, responsiveness) and providing continuous data will be considered sufficiently similar to allow statistical pooling. Outcomes will be presented short term (≤3 months follow-up), medium term (\>3, ≤12 months) and long term (\>12 months). Short-term outcomes, reflecting the early postoperative period, and long-term outcomes are considered the time points of main interest.

Risk of bias in individual studies {#s2i}
----------------------------------

Risk of bias for each included prospective cohort study will be independently assessed by the same initial reviewers. The third reviewer will again mediate in situations of disagreement. Cohen's κ will be used to assess agreement between reviewers. All tools and processes will be piloted a priori on ≥5 studies. Risk of bias will be assessed using a modified QUality In Prognostic Studies (QUIPS) tool.[@R22] The QUIPS tool was designed to assess risk of bias in prognostic factor studies that ideally use a prospective cohort design. The wording of key issues in some sections required revision; and as the prognostic factors section was not relevant to this review it was subsequently removed. These modifications were also informed by Pengel *et al*[@R23] who in their review of the prognosis of low back pain, including its natural course, collated six validity criteria from the existing literature. Through an iterative process the modified tool was developed and agreed. The definitive tool consists of eight components as detailed in [table 1](#BMJOPEN2015010571TB1){ref-type="table"}. A risk of bias, low, moderate or high, will be provided for each component in line with QUIPS[@R22]; a narrative summary will be included in tabular form as illustrated by the example included in [table 2](#BMJOPEN2015010571TB2){ref-type="table"}. A critical evaluation of study risk of bias will be presented in the context of its impact on study results. This will be achieved through summarising the assessment of risk of bias items within each study, and across studies for each time point.

###### 

ROB assessment (adapted from QUIPS[@R22]and Pengel *et al*[@R23])

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study           Study participation[@R22]\                                                                                                                                  Defined sample[@R23]\                                                                      Study attrition/complete follow-up[@R22]\                                                 Outcome measurement[@R22]\                                                  Study confounding[@R22]\                                        Statistical analysis and reporting[@R22]\                                     Provision of data[@R23]\                                             Blinded outcome[@R23]\                                                           Overall statement of risk of bias\
                  Representative sample[@R23]\                                                                                                                                Description of source of participants and evaluation of inclusion and exclusion criteria   Data related to outcome may be different for completing and non-completing participants   Measurement of the outcome may be different related to the baseline level   Outcome may be distorted by another factor related to outcome   Reported results may be spurious or biased related to analysis or reporting   Studies must provide raw data, percentages, or continuous outcomes   Assessor blinded and unaware of other measures at time of outcome was measured   Number of low, moderate and high ratings
                  Data related to outcome may be different for participants and eligible non-participants/participants selected by random selection or as consecutive cases                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  --------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------- --------------------------------------------------------------------------- --------------------------------------------------------------- ----------------------------------------------------------------------------- -------------------------------------------------------------------- -------------------------------------------------------------------------------- ------------------------------------------
  Example study   *Moderate ROB*\                                                                                                                                             *Moderate ROB*\                                                                            *Moderate ROB*\                                                                           *Low ROB*\                                                                  *Moderate ROB*\                                                 *Low ROB*\                                                                    *Low ROB*\                                                           *Low ROB*\                                                                       Low 4\
                  Some eligibility criteria, for example, prolapse \<6 mm may contribute to potential participants being excluded\                                            Clear eligibility criteria based on detailed physical examination and radiology findings   No losses to follow-up at 6 months\                                                       VAS 0--10 in cm\                                                            Possible interventions not reported                             Sufficient presentation of data\                                              Raw data, mean and SD reported                                       Independent assessor collected data                                              Moderate 4\
                  Suggests consecutive patients were considered                                                                                                                                                                                                          8 (16%) patients lost to follow-up at 12 months                                           Established measurement properties\                                                                                                         No selective reporting of results                                                                                                                                                                                                   High 0
                                                                                                                                                                                                                                                                                                                                                                   Measure standardised by independent assessor                                                                                                                                                                                                                                                                                                                                    

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: prognostic factor section of QUIPS not relevant.

QUIPS, QUality In Prognostic Studies; ROB, risk of bias; VAS, visual analogue scale.

Data synthesis {#s2j}
--------------

If enough studies are included, a meta-analysis will be conducted using the disability and pain outcome data. Authors will be contacted to request either raw data, or additional summary statistics for those reported when data or details of variance are missing. Data will be extracted for time points where follow-up is at least 80%.[@R23] Continuous outcome data will be presented in the original scale or converted to a 0--100 scale. When means or medians are not available, the midpoint of the range will be used. Means and 95% CIs will be plotted over time for pain and disability. When outcome data can be pooled across studies and follow-up time points (ie, short term, intermediate term and long term), n weighted pooled means will be used.[@R23] If included studies have provided variance data, the variance weighted mean will be used in the meta-analyses. In the situation that several studies do not provide variance data, the n weighted mean will be used. Day 1 (ie, day of surgery) will be taken as the reference time. The influence of potential predictor variables will be explored where possible using metaregression analyses. Predictor variables of interest identified a priori include type of surgery, duration of symptoms prior to surgery, age at time of surgery, level of education, work satisfaction, coexistence of psychological complaints, evidence of passive avoidance coping function,[@R24] level of preoperative pain and duration of sick leave (A Rushton, K Zoulas, A Powell, *et al*. Physical prognostic factors in lumbar discectomy surgery (PROSPERO 2015:CRD42015024168). In the case of significant findings, analyses per subgroup will be presented alongside the overall analyses.[@R13]

Metabiases {#s2k}
----------

Assessment of any publication bias across studies will be included. This will involve an analysis of consistency between published protocols and study findings, a detailed search for unpublished studies, and consideration of competing interests from various research groups. Results will be reported narratively.

Confidence in cumulative evidence {#s2l}
---------------------------------

The strength of the overall body of evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) method. A systematic review of cohort studies within the field of prognosis has previously been argued at the start as evidence of high quality.[@R25] Iorio *et al*[@R25] support that GRADE\'s five domains of rating quality down (risk of bias and publication bias as detailed above, and imprecision, inconsistency and indirectness) and up (adaptation of two (large effect, dose--response gradient) of the three GRADE domains) apply equally to studies investigating prognosis. The GRADE domains of interest will be adapted for cohort studies as recommended by Iorio *et al*.[@R25] This will enable a consistent method for evaluating confidence in estimates from the included studies in the review.

Discussion {#s3}
==========

This systematic review will, through a rigorous methodology, identify and examine studies reporting the natural course of pain and disability over time following the first lumbar discectomy. No systematic review has previously addressed this objective although Parker *et al*[@R26], in a recent synthesis across all published cohorts, did evaluate the frequency of recurrent symptoms and reoperation following lumbar discectomy. They identified that ongoing leg/back pain was a problem for 3--34% patients in the short term (6--24 months, 39 cohorts, n=8156 patients), and for 5--36% patients in the long term (\>24 months, 28 cohorts, n=6255). The incidence of recurrence (70 cohorts, n=18 085) of herniation ranged from 0% to 23%.[@R26]

Although risk of bias and overall level of evidence may limit analyses and confidence in this review\'s conclusions, this best evidence synthesis will provide a better understanding of the natural course of patient recovery postsurgery.

Implications of results {#s3a}
-----------------------

This review will provide the first rigorous summary of the course of pain and disability across all published prospective cohorts of adult patients following first lumbar discectomy. The findings will inform our understanding of when to offer and how to optimise rehabilitation for pain and disability following surgery.
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